Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

425- 431


Authors Details

Lalit Pawaskar*, Amit Sharma, Mayuresh Kiran, Mayuresh Kiran


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 439

PDF Downloaded: 182


Post-marketing surveillance study to compare the efficacy and safety by investigating the combination of Vitamin C, Vitamin E, Lutein, Zeaxanthin, Zinc and Copper with the combination of Astaxanthin, L-Glutathione and Lutein (contains Zeaxanthin) in patients of dry age-related macular degeneration (AMD)


Original Article

Author Details : Lalit Pawaskar*, Amit Sharma, Mayuresh Kiran, Mayuresh Kiran

Volume : 9, Issue : 3, Year : 2023

Article Page : 425-431

https://doi.org/10.18231/j.ijceo.2023.081



Suggest article by email

Get Permission

Abstract

Purpose: To determine the comparative efficacy and safety of Investigational Product – 1 (combination of Vitamin C, Vitamin E, Lutein, Zeaxanthin, Zinc and Copper) with Investigational product 2 (combination of Astaxanthin, L-Glutathione and Lutein (contains Zeaxanthin)) in patients for the indication of dry age-related macular degeneration (AMD).
Materials and Methods: It was an academic, prospective, open labelled, parallel, randomized, multicentric, comparative post-marketing surveillance study. The study was conducted at 5 clinical trial sites with 40 patients at each site. Patients with confirmed diagnosis of dry AMD in right or left or both eyes who met study inclusion and exclusion criteria were recruited for the study. The study duration was of 365 days and during the same patients were asked to visit the clinical trial site on day 30, 180 and 365 for the safety and efficacy assessment. Visual acuity, vision related quality of life and visual impairment questionnaire were the efficacy assessment parameters evaluated.
Results: Total 181 patients completed the study. It was found that there was statistically significant difference in the patients treated with the investigational product 1 and 2 for the efficacy assessment parameter, visual acuity (p value 0.0102) and vision related quality of life (p value 0.0013) and for visual impairment questionnaire score, no statistically significant difference was found (p value 0.0747).
Conclusion: Investigational product 1 was found to be more efficacious as compared to investigational product 2 for the efficacy assessment parameters visual acuity and vision related quality of life. Whereas for visual impairment questionnaire score i.e. vision required for the daily work, both products were found to be equally efficient.
 

Keywords: Vitamin C, Vitamin E, Lutein, Zeaxanthin, Zinc, Copper, Astaxanthin, L­ Glutathione.


How to cite : Pawaskar L, Sharma A, Kiran M, Kiran M, Post-marketing surveillance study to compare the efficacy and safety by investigating the combination of Vitamin C, Vitamin E, Lutein, Zeaxanthin, Zinc and Copper with the combination of Astaxanthin, L-Glutathione and Lutein (contains Zeaxanthin) in patients of dry age-related macular degeneration (AMD). Indian J Clin Exp Ophthalmol 2023;9(3):425-431

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.